Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data

相似書籍

• Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data
  由: Julita Anna Krahel, et al.
  出版: (2020-03-01)
• Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis
  由: Baran, Anna, et al.
  出版: (2020)
• Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
  由: Julia Nowowiejska, et al.
  出版: (2022-04-01)
• Proprotein Convertase Subtilisin/Kexin Type 9, Angiopoietin-Like Protein 8, Sortilin, and Cholesteryl Ester Transfer Protein—Friends of Foes for Psoriatic Patients at the Risk of Developing Cardiometabolic Syndrome?
  由: Krahel, Julita Anna, et al.
  出版: (2020)
• Aberrations in Lipid Expression and Metabolism in Psoriasis
  由: Nowowiejska, Julia, et al.
  出版: (2021)